PRESTIGE CONSMR (PBH)
(Delayed Data from NYSE)
$70.47 USD
+0.33 (0.47%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $70.54 +0.07 (0.10%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PBH 70.47 +0.33(0.47%)
Will PBH be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PBH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PBH
Prestige Consumer Healthcare (PBH) Earnings Expected to Grow: What to Know Ahead of Q4 Release
Here's Why You Should Retain Prestige Consumer (PBH) Stock Now
PBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes
Other News for PBH
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
PointsBet Announces Generous Capital Return
PointsBet Announces Cash Return to Shareholders
EXCLUSIVE LAUNCHES THIS KITCHEN DAY AT TVSN
PointsBet Director Adjusts Shareholdings